John Whysner
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment 21
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 6
- Biochemistry top 5%
- Amino Acid Enzymes and Metabolism 3
-
- Effects and risks of endocrine disrupting chemicals 7
- Toxic Organic Pollutants Impact 5
- Chemical Health and Safety top 5%
-
- Genomics, phytochemicals, and oxidative stress 5
- DNA Repair Mechanisms 3
-
- Hormonal and reproductive studies 3
- Co-authors
- Gary M. WilliamsMichael J. IatropoulosLynne VernaC. Clifford ConawayBoyd W. HardingPeter Maimon RossGordon C. HardM. Vijayaraj Reddy
- Journals
- Pharmacology & Therapeutics (8 papers)Regulatory Toxicology and Pharmacology (3 papers)Food and Chemical Toxicology (2 papers)
- Partner nations
- United StatesSwitzerlandDenmark
In The Last Decade
John Whysner
43 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 133
- Cancer Research 596
- Pharmacology 281
- Biochemistry 173
- Health, Toxicology and Mutagenesis 395
- Chemical Health and Safety 18
Countries citing papers authored by John Whysner
This map shows the geographic impact of John Whysner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Whysner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Whysner more than expected).
Fields of papers citing papers by John Whysner
This network shows the impact of papers produced by John Whysner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Whysner. The network helps show where John Whysner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Whysner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 1 | |
| 2 | 2011 | 118 | |
| 3 | 2005 | 23 | |
| 4 | 2003 | 10 | |
| 5 | 2003 | 147 | |
| 6 | 2001 | 33 | |
| 7 | 2000 | 27 | |
| 8 | 1999 | 305 | |
| 9 | 1998 | 26 | |
| 10 | 1998 | 37 | |
| 11 | 1996 | 22 | |
| 12 | 1996 | 39 | |
| 13 | 1996 | 45 | |
| 14 | 1996 | 29 | |
| 15 | 1996 | 188 | |
| 16 | 1996 | 47 | |
| 17 | 1996 | 50 | |
| 18 | 1994 | 40 | |
| 19 | 1992 | 13 | |
| 20 | 1966 | 12 |
About John Whysner
John Whysner is a scholar working on Chemical Health and Safety, Cancer Research, Biochemistry, Health, Toxicology and Mutagenesis and Pharmacology, having authored 44 papers that have together received 2.0k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (21 papers), Effects and risks of endocrine disrupting chemicals (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers), Toxic Organic Pollutants Impact (5 papers), Amino Acid Enzymes and Metabolism (3 papers), DNA Repair Mechanisms (3 papers) and Hormonal and reproductive studies (3 papers). The work is most often cited by research in Cancer Research (596 citations), Pharmacology (281 citations), Biochemistry (173 citations), Health, Toxicology and Mutagenesis (395 citations) and Chemical Health and Safety (18 citations). John Whysner has collaborated with scholars based in United States, Switzerland and Denmark. Frequent co-authors include Gary M. Williams, Michael J. Iatropoulos, Lynne Verna, C. Clifford Conaway, Boyd W. Harding, Peter Maimon Ross, Gordon C. Hard, M. Vijayaraj Reddy, Marie‐Claude Jaurand and Tom K. Hei. Their work appears in journals such as Pharmacology & Therapeutics, Regulatory Toxicology and Pharmacology, Food and Chemical Toxicology, Preventive Medicine and Toxicon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.